Small cell pattern of ALK‐negative anaplastic large cell lymphoma with double‐hit rearrangements of DUSP22 and TP63
Open Access
Abstract
In ALK‐negative anaplastic large cell lymphoma (ALCL), gene rearrangements of DUSP22 and TP63 are considered mutually exclusive. The former predicts a favorable prognosis, while the latter is generally unfavorable. We report the first case of ALK‐negative ALCL in a leukemic phase with small cell pattern transformation, harboring double‐hit rearrangements of the DUSP22 gene by inv(6)(p25q21) and TP63 gene by TBL1XR1‐TP63 inversion. Despite the resistance to chemotherapies, the patient remained in remission with allogeneic stem cell transplantation over 20 months. Recognizing this pathologically and genetically rare condition is needed for prompt diagnosis and therapeutic decision‐making in ALK‐negative ALCL.Keywords
This publication has 15 references indexed in Scilit:
- Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phaseBlood, 2022
- Co-occurring rearrangements of DUSP22 and TP63 define a rare genetic subset of ALK-negative anaplastic large cell lymphoma with inferior survival outcomesLeukemia & Lymphoma, 2021
- Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphomaNature Communications, 2021
- “Double-hit” of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negativeBlood, 2020
- Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case reportAnnals of Medicine & Surgery, 2020
- Fluorescence in‐situ hybridisation for TP63 rearrangements in T cell lymphomas: single‐site experience of 470 patients and implications for clinical testingHistopathology, 2019
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomesBlood, 2014
- ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as “leukemic phase”Leukemia Research, 2010
- CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical featuresBlood, 2000
- Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four casesBritish Journal of Haematology, 1999